All News

In a comprehensive systematic review that assessed risk factors for HZ infection, researchers found that immunosuppression through HIV/AIDS or malignancy places individuals at a significant risk.

More than half of high-risk patients with resected, stage III BRAF V600-mutated melanoma who were treated with dabrafenib and trametinib were alive and relapse-free at 5 years.

Lactic acid, citric acid, and potassium bitartrate is a prescription combination, non-hormonal contraceptive gel found to be 86.3% effective with typical use.

In recent years, many improvements have been made in the continuous glucose monitoring arena for individuals with diabetes, and there are more products on the horizon.

New refining process helps to minimize odor and taste from fish oil supplements.

NACDS and NASPA have been encouraging state legislators to promote the critical public health message of the importance of flu vaccination this year.

Dr. Reddy’s Laboratories announced the launch of fulvestrant injection, 250 mg/5 mL per single-dose syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant).

Seven cases of young people with stiffness throughout their body and an inability to speak presented to hospitals in different cities throughout the country, with seemingly no link between them.

September has been designated as National Sickle Cell Awareness Month for the continued fostering of education surrounding sickle cell disease management.

Study participants who had dietician sessions, an exercise physiologist session, and online brain training had higher cognition scores after 6 months.

Technology can help revolutionize how a pharmacy manages patients, collects payments, communicates, and can improve overall efficiency.

Clinical education, strong data analytics, and valuing collaboration are the best ways to provide patient support and access to specialty pharmaceutical manufacturers.

Protections for covered entities under the 340B program will most likely be affected by decisions in the Senate.

Agency strongly encourages vaccination of flu amidst COVID-19 pandemic to protect nation’s seniors.

Methylphenidate Hydrochloride extended-release tablets are a therapeutic equivalent generic version of Concerta (methylphenidate Hydrochloride) extended-release tablets.

The new study suggests that COVID-19 will follow the track of other respiratory viruses and become seasonal in countries with temperate climates, but only when herd immunity is attained through natural infection or vaccinations.

Study shows the recurrence rate was within the expected range for breast cancer survivors receiving spironolactone and those who did not.

Data standardization has been an ongoing problem in the specialty pharmacy field, affecting both patients and providers when approaching treatments.

Top news of the week from Pharmacy Times®.

In which city can you find a tiny mouse-sized pharmacy?

In this episode of OnScript with NHA, co-hosts Jessica Langley-Loep and Jeremy Sasser are joined by Susan Bonilla, the newly-appointed CEO of the California Pharmacists Association.

Dr. Reddy’s Laboratories Ltd announced the launch of over-the-counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain, in the US market.

During the COVID-19 pandemic, many families and individuals have not been able to pay their out-of-pocket costs or do not have enough money saved to pay their deductibles.

Political insiders Donna L. Brazile and Michael Steele spoke to NASP members about which issues may concern them most and getting involved in the political process.

A new test may help direct treatments for patients with rare breast cancer mutations.

In June 2020, 56% of people over 50 years of age said they sometimes or often felt isolated from others, more than double the 27% who felt this way in a similar poll in 2018.

This week’s pharmacy management Tip of the Week takes a look at establishing a clinical pharmacy site in the emergency department (ED) of a hospital.

The CINtec PLUS Cytology assay is indicated for women who undergo cervical cancer screening and test positive for high-risk types of human papillomavirus.